From Our Partners
Sunday, July 3, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

CDC Novel Coronavirus Diagnostic Ships Out to Public Health Labs

by Global Biodefense Staff
February 5, 2020
CDC Novel Coronavirus Diagnostic Ships Out to Public Health Labs

This is a picture of CDC’s laboratory test kit for the 2019 novel coronavirus (2019-nCoV). CDC is shipping the test kits to laboratories CDC has designated as qualified, including U.S. state and local public health laboratories, Department of Defense (DOD) laboratories and select international laboratories. The test kits are bolstering global laboratory capacity for detecting 2019-nCov.

The CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel is ready for distribution to qualified laboratories for detection of 2019 novel coronavirus.

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) on February 4, 2020, to enable emergency use of the test kit in the United States. CDC has produced EUA and Research Use Only (RUO) test kits that are now available to order by domestic and international public health partners through International Reagents Resource.

CDC’s diagnostic panel is intended for use by laboratories designated by CDC as qualified, and in the United States, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. This includes U.S. state and local public health laboratories and Department of Defense (DoD) laboratories. The test kits also will be shipped to qualified international laboratories, such as World Health Organization (WHO) Global Influenza Surveillance Response System (GISRS) laboratories.

“Today the test kits will start shipping to the over 100 US public health labs, each of these labs is required to perform international verification for CLIAA compliance prior to reporting out.  This process is expected to take a few days. Initially 200 test kits will be distributed to US domestic laboratories and another 200 will be distributed to selected international laboratories,” said Dr. Nancy Messonier, Director of the CDC’s National Center for Immunization and Respiratory Diseases. “Each test kit can perform 700 to 800 patient samples. What that means is that by the start of next week, we expect there to be much enhanced capacity for laboratory testing closer to our patients..

Each laboratory that places an order will receive one diagnostic panel initially, and each panel can test 700-800 patient specimens.

The CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel contains the following:

  • 2019-nCoV_N1, 2019-nCoV_N2 and 2019-nCoV_N3 primers and probes that target the nucleocapsid (N) gene and are designed for both universal detection of SARS-like coronavirus as well as specific detection of the 2019-nCoV;
  • RP primers and probes that target the Human RNase P gene; and
  • nCoVPC, the 2019-nCoV positive control used in the assay.

Dr. Messonnier noted that the important role of state public health systems will be more visible to the general public in coming days. “States will now start testing for and confirming this virus and you may start hearing from states directly about confirmed cases.  As always, their case count will be the most up-to-date…US public health system relies heavily on the work of state, local and territorial health departments who are on the front lines of outbreak responses.  Their ability to detect and confirm this virus is critical.”

Sources: CDC, IRR

From Our Partners
Tags: CoronavirusCOVID-19Editor PickEpidemiologyFrontline RespondersMagazine Edition 6 Feb 2020Public Health EmergencyRapid Diagnostics

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC